Clinical Trial Update: Administration of Intranasal Midazolam for Anxiety in Palliative Care [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intranasal midazolam for anxiety in palliative care is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Anxiety, Acute Anxiety | Phase 2 | Status: RECRUITING